Revisiting the T-cell receptor alpha/delta locus and possible associations with multiple sclerosis

Genes and Immunity

Volumn 12, Issue 2, 2011, Pages 59-66

  Watson, C T ^a   Para, A E ^b   Lincoln, M R ^b,c   Ramagopalan, S V ^b,c,d   Orton, S M ^b,c   Morrison, K M ^b   Handunnetthi, L ^b,c   Handel, A E ^b,c   Chao, M J ^b,c   Morahan, J ^b,c   Sadovnick, A D ^e   Breden, F ^a   Ebers, G C ^b,c  

^a SIMON FRASER UNIVERSITY   (Canada)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

genetics; multiple sclerosis; T cell receptor

Indexed keywords

T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN;

GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

COHORT STUDIES; GENES, T-CELL RECEPTOR ALPHA; GENES, T-CELL RECEPTOR DELTA; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES;

EID: 79952283404     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2010.65     Document Type: Review

References (70)

1. Sawcer S. The complex genetics of multiple sclerosis: pitfalls and prospects. Brain 2008; 131: 3118-3131.
2. Handel AE, Giovannoni G, Ebers GC, Ramagopalan SV. Environmental factors and their timing in adult-onset multiple sclerosis. Nat Rev Neurol 2010; 6: 156-166.
3. Lincoln MR, Montpetit A, Cader MZ, Saarela J, Dyment DA, Tiislar M et al. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet 2005; 37: 1108-1112. (Pubitemid 41486664)
4. Dyment DA, Herrera BM, Cader MZ, Willer CJ, Lincoln MR, Sadovnick AD et al. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum Mol Genet 2005; 14: 2019-2026. (Pubitemid 41418037)
5. Ramagopalan SV, Morris AP, Dyment DA, Herrera BM, DeLuca GC, Lincoln MR et al. The inheritance of resistance alleles in multiple sclerosis. PLoS Genet 2007; 3: 1607-1613. (Pubitemid 47510254)
6. Chao MJ, Barnardo MCNM, Lincoln MR, Ramagopalan SV, Herrera BM, Dyment DA et al. HLA class I alleles tag HLADRB1*.haplotypes for differential risk in multiple sclerosis susceptibility. Proc Natl Acad Sci USA 2008; 105: 13069-13074.
7. Lincoln MR, Ramagopalan SV, Chao MJ, Herrera BM, Deluca GC, Orton S-M et al. Epistasis among HLA-DRB1, HLADQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility. Proc Natl Acad Sci USA 2009; 106: 7542-7547.
8. Ramagopalan SV, Ebers GC. Epistasis: multiple sclerosis and the major histocompatibility complex. Neurology 2009; 72: 566-567.
9. Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007; 357: 851-862. (Pubitemid 47347319)
10. Lundmark F, Duvefelt K, Iacobaeus E, Kockum I, Wallström E, Khademi M et al. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet 2007; 39: 1108-1113. (Pubitemid 47340654)
11. Aulchenko YS, Hoppenbrouwers IA, Ramagopalan SV, Broer L, Jafari N, Hillert J et al. Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis. Nat Genet 2008; 40: 1402-1403.
12. Hoppenbrouwers IA, Aulchenko YS, Ebers GC, Ramagopalan SV, Oostra BA, van Duijn CM et al. EVI5 is a risk gene for multiple sclerosis. Genes Immun 2008; 9: 334-337. (Pubitemid 351791489)
13. De Jager PL, Jia X, Wang J, de Bakker PIW, Ottoboni L, Aggarwal NT et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 2009; 41: 776-782.
14. Baranzini SE, Wang J, Gibson RA, Galwey N, Naegelin Y, Barkhof F et al. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet 2009; 18: 767-778.
15. Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene). Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes .12. and 20. Nat Genet 2009; 41: 824-828.
16. International Multiple Sclerosis Genetics Consortium (IMSGC). Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci. Hum Mol Genet 2010; 19: 953-962.
17. Ebers G, Sadovnick A, Dyment D, Yee I, Willer C, Risch N. Parent-of-origin effect in multiple sclerosis: observations in half-siblings. The Lancet 2004; 363: 1773-1774. (Pubitemid 38698382)
18. Herrera BM, Ramagopalan SV, Lincoln MR, Orton SM, Chao MJ, Sadovnick AD et al. Parent-of-origin effects in MS: observations from avuncular pairs. Neurology 2008; 71: 799-803.
19. Hoppenbrouwers IA, Liu F, Aulchenko YS, Ebers GC, Oostra BA, van Duijn CM et al. Maternal transmission of multiple sclerosis in a Dutch population. Arch Neurol 2008; 65: 345-348. (Pubitemid 351398519)
20. Ramagopalan SV, Yee IM, Dyment DA, Orton S-M, Marrie RA, Sadovnick AD et al. Parent-of-origin effect in multiple sclerosis: observations from interracial matings. Neurology 2009; 73: 602-605.
21. Ramagopalan SV, Herrera BM, Bell JT, Dyment DA, Deluca GC, Lincoln MR et al. Parental transmission of HLA-DRB1*15 in multiple sclerosis. Hum Genet 2008; 122: 661-663.
22. Chao MJ, Ramagopalan SV, Herrera BM, Lincoln MR, Dyment DA, Sadovnick AD et al. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex. Hum Mol Genet 2009; 18: 261-266.
23. Ebers GC. Environmental factors and multiple sclerosis. Lancet Neurol 2008; 7: 268-277. (Pubitemid 351222732)
24. Ramagopalan SV, Maugeri NJ, Handunnetthi L, Lincoln MR, Orton S-M, Dyment DA et al. Expression of the multiple sclerosis-associated MHC class II allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet 2009; 5: e1000369.
25. McFarland HF, Martin R. Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol 2007: 8, 913-919. (Pubitemid 47300005)
26. Brucklacher-Waldert V, Stuerner K, Kolster M, Wolthausen J, Tolosa E. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain 2009; 132: 3329-3341.
27. Jäger A, Dardalhon V, Sobel RA, Bettelli E, Kuchroo VK. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol 2009; 183: 7169-7177.
28. Du C, Liu C, Kang J, Zhao G, Ye Z, Huang S et al. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol 2009; 10: 1252-1259.
29. Gandhi KS, McKay FC, Cox M, Riveros C, Armstrong N, Heard RN et al. The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis. Hum Mol Genet 2010; 19: 2134-2143.
30. Martell M, Marcadet A, Strominger J, Dausset J, Cohen D. T-cell receptor alpha genes might be involved in multiple sclerosis genetic susceptibility. C R Acad Sci III 1987; 304: 105-110. (Pubitemid 17069368)
31. Oksenberg JR, Gaiser CN, Cavalli-Sforza LL, Steinman L. Polymorphic markers of human T-cell receptor alpha and beta genes. Family studies and comparison of frequencies in healthy individuals and patients with multiple sclerosis and myasthenia gravis. Hum Immunol 1988; 22: 111-121.
32. Oksenberg JR, Sherritt M, Begovich AB, Erlich HA, Bernard CC, Cavalli-Sforza LL et al. T-cell receptor Valpha and C alpha alleles associated with multiple and myasthenia gravis. Proc Natl Acad Sci USA 1989; 86: 988-992. (Pubitemid 19056275)
33. Oksenberg JR, Stuart S, Begovich AB, Bell RB, Erlich HA, Steinman L et al. Limited heterogeneity of rearranged T-cell receptor V alpha transcripts in brains of multiple sclerosis patients. Nature 1990; 345: 344-346.
34. Hashimoto LL, Mak TW, Ebers GC. T cell receptor alpha chain polymorphisms in multiple sclerosis. J Neuroimmunol 1992; 40: 41-48.
35. Hillert J, Leng C, Olerup O. T-cell receptor alpha chain germline gene polymorphisms in multiple sclerosis. Neurology 1992; 42: 80-84.
36. Lynch SG, Rose JW, Petajan JH, Leppert M. Discordance of the T-cell receptor alpha-chain gene in familial multiple sclerosis. Neurology 1992; 42: 839-844.
37. Sherritt MA, Oksenberg J, de Rosbo NK, Bernard CC. Influence of HLA-DR2, HLA-DPw4, and T cell receptor alpha chain genes on the susceptibility to multiple sclerosis. Int Immunol 1992; 4: 177-181.
38. Eoli M, Wood NW, Kellar-Wood HF, Holmans P, Clayton D, Compston DA. No linkage between multiple sclerosis and the T cell receptor alpha chain locus. J Neurol Sci 1994; 124: 32-37. (Pubitemid 24183991)
39. Vandevyver C, Buyse I, Philippaerts L, Ghabanbasani Z, Medaer R, Carton H et al. HLA and T-cell receptor polymorphisms in Belgian multiple sclerosis patients: no evidence for disease association with the T-cell receptor. J Neuroimmunol 1994; 52: 25-32. (Pubitemid 24182242)
40. Droogan AG, Kirk CW, Hawkins SA,McMillan SA, Nevin NC, Graham CA. T-cell receptor alpha, beta, gamma, and delta chain gene microsatellites show no association with multiple sclerosis. Neurology 1996; 47: 1049-1053.
41. Seboun E, Robinson MA, Doolittle TH, Ciulla TA, Kindt TJ, Hauser SL. A susceptibility locus for multiple sclerosis is linked to the T cell receptor beta chain complex. Cell 1989; 57: 1095-1100. (Pubitemid 19169805)
42. Beall SS, Biddison WE, McFarlin DE, McFarland HF, Hood LE. Susceptibility for multiple sclerosis is determined, in part, by inheritance of a 175-kb region of the TcR V beta chain locus and HLA class II genes. J Neuroimmunol 1993; 45: 53-60. (Pubitemid 23224381)
43. Dyment DA, Steckley JL, Morrison K, Willer CJ, Cader MZ, DeLuca GC et al. TCR beta polymorphisms and multiple sclerosis. Genes Immun 2004; 5: 337-342. (Pubitemid 39139759)
44. Murphy KM, Travers P, Walport M. Janeway's Immunobiology 7th edn Garland Science: London, 2007.
45. Freeman JD, Warren RL, Webb JR, Nelson BH, Holt RA. Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing. Genome Res 2009; 19: 1817-1824.
46. Wang C, Sanders CM, Yang Q, Schroeder HW, Wang E, Babrzadeh F et al. High throughput sequencing reveals a complex pattern of dynamic interrelationships among human T cell subsets. Proc Natl Acad Sci USA 2010; 107: 1518-1523.
47. Utz U, Biddison WE, McFarland HF, McFarlin DE, Flerlage M, Martin R. Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis. Nature 1993; 364: 243-247. (Pubitemid 23257083)
48. Haegert DG, Galutira D, Murray TJ, O'Connor P, Gadag V. Identical twins discordant for multiple sclerosis have a shift in their T-cell receptor repertoires. Clin Exp Immunol 2003; 134: 532-537. (Pubitemid 37542096)
49. Somma P, Ristori G, Battistini L, Cannoni S, Borsellino G, Diamantini A et al. Characterization of CD8+ T cell repertoire in identical twins discordant and concordant for multiple sclerosis. J Leukoc Biol 2007; 81: 696-710. (Pubitemid 46393547)
50. Nikolich-Zugich J, Slifka MK, Messaoudi I. The many important facets of T-cell repertoire diversity. Nat Rev Immunol 2004; 4: 123-132. (Pubitemid 38209206)
51. Lefranc M-P, Lefranc G. The T Cell Receptor Factbook. Academic Press: London, 2001.
52. Rudolph MG, Wilson IA. The specificity of TCR/pMHC interaction. Curr Opin Immunol 2002; 14: 52-65. (Pubitemid 34085107)
53. Cabaniols JP, Fazilleau N, Casrouge A, Kourilsky P, Kanellopoulos JM. Most ab T cell receptor diversity is due to terminal deoxynucleotidyl transferase. J Exp Med 2001; 194: 1385-1390. (Pubitemid 33055055)
54. Koop BF, Rowen L, Wang K, Kuo CL, Seto D, Lenstra JA et al. The human T-cell receptor TCRAC/TCRDC (C alpha/C delta) region: organization, sequence, and evolution of 97.6 kb of DNA. Genomics 1994; 19: 478-493. (Pubitemid 24071322)
55. Lefranc M-P, Giudicelli V, Ginestoux C, Jabado-Michaloud J, Folch G, Bellahcene F et al. IMGT, the international ImMuno- GeneTics information system. Nucleic Acids Res 2009; 37: D1006-D1012.
56. Ho IC, Yang LH, Morle G, Leiden JM. A T-cell-specific transcriptional enhancer element 30 of C alpha in the human T-cell receptor alpha locus. Proc Natl Acad Sci USA 1989; 86: 6714-6718. (Pubitemid 19236334)
57. Redondo JM, Hata S, Brocklehurst C, Krangel MS. A T cellspecific transcriptional enhancer within the human T cell receptor delta locus. Science 1990; 247: 1225-1229.
58. Mackelprang R, Livingston RJ, Eberle MA, Carlson CS, Yi Q, Akey JM et al. Sequence diversity, natural selection and linkage disequilibrium in the human T cell receptor alpha/ delta locus. Hum Genet 2006; 119: 255-266.
59. Moffatt MF, Traherne JA, Abecasis GR, Cookson WO. Single nucleotide polymorphism and linkage disequilibrium within the TCR alpha/delta locus. Hum Mol Genet 2000; 9: 1011-1019. (Pubitemid 30216006)
60. Haines JL, Terwedow HA, Burgess K, Pericak-Vance MA, Rimmler JB, Martin ER et al. Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group. Hum Mol Genet 1998; 7: 1229-1234. (Pubitemid 28383054)
61. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273: 1516-1517. (Pubitemid 26301653)
62. Sadovnick AD, Risch NJ, Ebers GC. Canadian collaborative project on genetic susceptibility to MS, phase 2: rationale and method. Canadian Collaborative Study Group. Can J Neurol Sci 1998; 25: 216-221. (Pubitemid 28368797)
63. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulindependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-516. (Pubitemid 23311321)
64. Spielman RS, Ewens WJ. The TDTand other family-based tests for linkage disequilibrium and association. Am J Hum Genet 1996; 59: 983-989. (Pubitemid 26346336)
65. Bronson PG, Caillier S, Ramsay PP, McCauley JL, Zuvich RL, De Jager PL et al. CIITA variation in the presence of HLADRB1* increases risk for multiple sclerosis. Hum Mol Genet 2010; 19: 2331-2340.
66. Hallmayer J, Faraco J, Lin L, Hesselson S, Winkelmann J, Kawashima M et al. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet 2009; 41: 708-711.
67. Fontana A, Gast H, Reith W, Recher M, Birchler T, Bassetti CL. Narcolepsy: autoimmunity, effector T cell activation due to infection, or T cell independent, major histocompatibility complex class II induced neuronal loss? Brain 2010; 133: 1300-1311.
68. Mignot E. Genetic and familial aspects of narcolepsy. Neurology 1998; 50: S16-S22. (Pubitemid 28100862)
69. Bassing CH, Tillman RE, Woodman BB, Canty D, Monroe RJ, Sleckman BP et al. T cell receptor (TCR) alpha/delta locus enhancer identity and position are critical for the assembly of TCR delta and alpha variable region genes. Proc Natl Acad Sci USA 2003; 100: 2598-2603. (Pubitemid 36297544)
70. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575. (Pubitemid 47330214)